.354) were similar in the robotic and laparoscopic groups. There were no statistical significance between-group differences in tumor size, operative time, estimated blood loss, perioperative hemoglobin change, length of hospital stay, and complication rates. Pathologic diagnosis showed that pheochromocytoma (21% vs. 3%) and metastatic tumor (24% vs. 6%) were more frequent in the robotic than in the laparoscopic group (p=0.019). Subgroup analysis of patients with low tumor volume (≤6.8 cm 3 ) showed that operation time was significantly shorter in the robotic than in the laparoscopic group (p=0.045).
INTRODUCTION
Laparoscopic adrenalectomy has become the standard treatment for removal of adrenal tumors. 1 This procedure has several advantages compared with open adrenalectomy, such as minimal invasiveness and shorter postoperative recovery and length of hospital stay. 2 The recent introduction of robotic technology into surgical practice has led to robot-assisted laparoscopic prostatectomy, nephrectomy, and many other urologic procedures. [3] [4] [5] The first robot-assisted laparoscopic adrenalectomy was described in 1999. 6 Robotic surgery has several advantages over pure laparoscopic surgery, including its 3-dimensional magnified vision, eliminating surgeon tremors and reducing surgeon fatigue during the operation. 7 These advantages are particularly important in optimizing surgery on patients with large-sized tumors and/or obesity. 8, 9 Studies comparing robotic and laparoscopic adrenalectomy have shown similar perioperative outcomes, including operative time, estimated blood loss (EBL), complications and length of hospital stay, although robotic surgery has some advantages in difficult-to-treat patients. 9, 10 For example, mean operation times in obese patients (body mass index [BMI]＞30 kg/m 2 ) and patients with large-sized tumors (＞55 mm) were shorter when performed robotically than by conventional laparoscopy. 10 To extend these findings, this study compared perioperative outcomes in patients undergoing robotic and laparoscopic adrenalectomy.
MATERIALS AND METHODS

Study Population
With Institutional Review Board approval, the medical records of all patients who underwent laparoscopic or robot-as- 
RESULTS
The clinical characteristics of the 63 patients who underwent laparoscopic adrenalectomy during the study period are shown in Table 1 . Of these 63 patients, 29 underwent robot-assisted and 34 underwent conventional laparoscopic adrenalectomy.
There were no significant differences in age, BMI, diabetes mellitus, and hypertension between the 2 groups. Seventeen patients (59%) in the robotic group and 11 (32%) in the laparoscopic group were male (p=0.037). Forty-seven patients (75%)
were incidentally diagnosed, and 2 patients had uncontrolled Histopathologic diagnosis showed that the percentages of patients with pheochromocytoma (21% vs. 3%) and metastatic tumor (24% vs. 6%) were significantly higher in the robotic than 
DISCUSSION
This current study describes the experience of our center with robotic and conventional laparoscopic adrenalectomy.
Outcomes of the 2 procedures were similar, with operation time, EBL, postoperative hemoglobin change, and length of stay not differing significantly in the two groups of patients.
Since its introduction, laparoscopic adrenalectomy has become the treatment of choice for resecting adrenal tumors. 1 This approach, however, has several disadvantages, including the limited maneuverability of the instruments and a 2-dimensional screen, making laparoscopic adrenalectomy hard to learn and requiring a long learning curve. 12 Robotic technology has overcome some of the limitations of laparoscopic adrenalectomy. and instruments with wrist joints, the mean operation times of the 2 procedures were similar. The robot system requires a longer setup time, including for docking of the robot and insertion of more ports than the laparoscopic procedure. The mean console time for robotic adrenalectomy was 67 minutes, indicating that half of the operating time was used to set up the robotic system.
Previous studies reported similar perioperative complication rates in patients who underwent robotic and laparoscopic adrenalectomy. For example, one study found that the postoperative complication rates were 7% and 11%, respectively, and the conversion rates were 0% and 9%, respectively, 14 and a second study found that the difference in postoperative complication rate was not statistically significant. 16 Another study reported no intraoperative complications in both groups and postoperative complication rates of 13% for robotic and 25%
for laparoscopic adrenalectomy. 9 In the current study, 3 patients in the robotic group experienced intraoperative complications, with one having a pleural injury and 2 having liver injuries. In conclusion, this study showed that robot-assisted laparoscopic adrenalectomy is technically feasible, with outcomes comparable to those of laparoscopic adrenalectomy. The robotic system has several advantages, including 3-dimensional magnified vision, elimination of surgeon tremor, and extended mobility of instruments with a wrist joint, making it more suitable than the laparoscopic procedure in difficult cases. However, the indications for robotic adrenalectomy must be more clearly defined.
CONCLUSIONS
Robot-assisted laparoscopic adrenalectomy is technically feasible, with outcomes comparable to those of laparoscopic adrenalectomy. The indications for robotic adrenalectomy must be more clearly defined.
